Severe community-acquired pneumonia

Current Opinion in Pulmonary Medicine

Volumn 2, Issue 3, 1996, Pages 186-191

  Cassiere, Hugh A ^a   Fein, Alan M ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BACTEREMIA; BACTERIAL PNEUMONIA; COMMUNICABLE DISEASE; HUMAN; MICROBIOLOGY; PRACTICE GUIDELINE; PROGNOSIS; PUBLIC HEALTH; REVIEW; SPUTUM;

ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES; PROGNOSIS; PUBLIC HEALTH; SPUTUM;

EID: 0030132955     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199605000-00005     Document Type: Article

References (34)

1. Pneumonia and influenza death rates-United States. MMWR Morb Mortal Wkly Rep 1995, 44:535-537. Report of the combined cause of death category pneumonia and influenza. The report states that this category ranks as the sixth leading cause of death in the United States.
2. American Thoracic Society: Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993, 148:1418-1426.
3. Woodhead MA, MacFarlane JT: Comparative clinical laboratory features on Legionella with pneumococcal and Mycoplasma pneumonias. Br J Dis Chest 1987, 81:133-139.
4. Farr BM, Kaiser DL, Harrison BW, Connolly CK: Prediction of microbial aetiology at admission to hospital for pneumonia from presenting clinical features. Thorax 1989, 44:1031-1035.
5. Macfarlane JT, Miller AC, Roderick Smith WH, Morris AH, Rose DH: Comparative radiographic features of community acquired Legionnaires' disease, pneumococcal pneumonia, Mycoplasma pneumonia, and psittacosis. Thorax 1984, 39:28-33.
6. Puren AJ, Feldman C, Savage N, Becker PJ, Smith C: Patterns of cytokine expression in community-acquired pneumonia. Chest 1995, 107:1342-1349.
7. Farr BM, Sloman AJ, Fisch MJ: Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 1991, 115:428-436.
8. British Thorax Society: Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors, and outcome. Q J Med 1987, 62:195-220.
9. Ewig S, Bauer T, Hasper E, Pizzulli L, Kubini R, Luderitz B: Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia. Eur Respir J 1995, 8:392-397. A retrospective review evaluating prognostic factors in 92 patients with CAP. The authors found that a lactic dehydrogenase level of higher than 260 u/L, systolic blood pressure of 80 mm Hg or less, and a heart rate of bpm or higher were associated with sixfold increase in mortality.
10. Almirall J, Mesalles E, Klamburg J, Para O, Agudo A: Prognostic factors of pneumonia requiring admission to the intensive care unit Chest 1995, 107:511-516. A prospective study evaluating the prognostic factors in 127 patients admitted to the ICU with severe pneumonia. The authors found that advanced age (70 years or older), Simplified Acute Physiology Score higher than 12, presence of septic shock, need for mechanical ventilation, bilateral pulmonary involvement, and infection caused by P. aeruginosa were all associated with fatal outcome from severe CAP.
11. Marfin AA, Sporrer J, Moore PS, Siefkin AD: Risk factors for adverse outcome in persons with pneumococcal pneumonia. Chest 1995, 107:457-462. A retrospective chart review of 102 patients with pneumococcal bacteremia and pneumonia. Factors associated with adverse outcome included nosocomial-acquired infection, age older than 48 years, preexisting lung disease, and a body temperature less than 38°C.
12. Jong GM, Hsiue TR, Chen CR, Chang HY, Chen CW: Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics. Chest 1995, 107:214-217. Retrospective chart review of 28 patients with alcohol abuse admitted with CAP. The authors found an overall mortality rate of 64.3%. In those patients with bacteremic K. pneumoniae (39.3%), the mortality rate was 100%. All patients with bacteremic K. pneumoniae required ICU care and mechanical ventilation, and all isolates were susceptible to the antibiotics used.
13. Fernandez-Sola JF, Junque A, Estruch R, Monforte R, Torres A, Urbano-Marquez A: High alcohol intake as a risk factor and prognostic factor for community-acquired pneumonia. Arch Intern Med 1995, 155:1649-1654. A case-control study of 50 patients with CAP and 50 controls, evaluating for independent risk factors associated with CAP. These authors found that the only independent factor associated with CAP was high alcoholic intake.
14. Feldman C, Ross S, Mahomed AG, Omar J, Smith C: The aetoliogy of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir Med 1995, 186:187-192. A retrospective chart review of 259 patients with severe CAP admitted to the ICU. These authors found a high incidence of infection with gram-negative bacteria, especially K. pneumoniae, which was second only to S. pneumoniae as the most common etiology of severe CAP.
15. Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P: Severe community-acquired pneumonia etiology, epidemiology, and prognostic factors. Chest 1994, 105:1487-1495. A prospective study evaluating 132 patients with severe CAP. The authors found that mortality was associated with age older than 60 years, septic shock, impaired alertness, mechanical ventilation requirement, bacteremic pneumonia, and S. pneumoniae or Enterobacteriaceae as the cause of pneumonia. This study found no mortality benefit in knowing the etiologic agent causing pneumonia.
16. Rello J, Quintana E, Ausina V, Net A, Prats G: A three year study of severe community-acquired pneumonia with emphasis on outcome. Chest 1993, 103:232-235.
17. Marston BJ, Lipman BB, Breiman RF: Surveillance for Legionnaires' disease. Arch Intern Med 1994, 154:2417-2422. A surveillance study of legionnaires' disease that found that the likelihood of death from this disease was increased in the elderly, in men, in those with hospital-acquired infection, in patients with renal or neoplastic disease, in immunosuppressed patients, and in those infected with L. pneumophilia serogroup 6.
18. Nava JM, Bella F, Garau J, Lite J, Morera MA, Marti C, Fontanals D, Font B, Pineda V, Uriz S, et al.: Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994, 19:884-890. A prospective study evaluating factors associated with invasive disease due to penicillin-resistant S. pneumoniae in 374 patients. Invasive disease secondary to intermediate-resistant S. pneumoniae is associated with immunosuppressive disease, previous β-lactam antibiotic use, previous hospitalization, and hospital-acquired infection. Invasive disease secondary to highly resistant S. pneumoniae was associated with previous β-lactam antibiotic use.
19. Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F: Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995, 333:474-480. A prospective study examining the effect of resistance to penicillin and cephalosporin on mortality in 504 patients with culture-proven pneumococcal pneumonia. The authors concluded that current levels of resistance to penicillin and cephalosporins by S. pneumoniae were not associated with increased mortality in patients with pneumococcal pneumonia.
20. Verweij PE, Meis JF, Eijk R, Melchers WJ, Galama JM: Severe human psittacosis requiring artificial ventilation: case report and review. Clin Infect Dis 1995, 120:440-442.
21. Torres A, Serra-batlles J, Ferrer A, Jimenez P, Cells R, Cobo E, Rodriguez-Roisin R: Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991, 144:312-318.
22. Leroy O, Santre C, Beuscart C, Georges H, Guery B, Jacquier JM, Beaucaire G: A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995, 21:24-31. A retrospective clinical study examining the epidemiology and prognosis of patients with severe CAP. Multivariate analysis selected five factors significantly associated with prognosis: anticipated death within 5 years, shock, bacteremia, non-pneumonia complications, and ineffective initial therapy.
23. British Thoracic Society and the Public Health Laboratory Service: Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987, 239:195-220.
24. Fine MJ, Orloff JJ, Rihs JD, Vickers RM, Kominos S, Kapoor WN, Arena VC, Yu VL: Evaluation of housestaff physicians' preparation and interpretation of sputum Grams' stains for community-acquired pneumonia. J Gen Intern Med 1991, 6:189-193.
25. Chalasani NP, Valdecanas ML, Gopal AK, McGowan JE, Jurado RL: Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks. Chest 1995, 108:932-936. A retrospective study evaluating the clinical utility of routine blood cultures in patients with CAP and no defined underlying risk factors. The study found that in patients without underlying risk factors (HIV, steroid dependence, malignancies, sickle cell disease, and nursing home residence), the yield of routine blood cultures is minimal (6.6%), and blood cultures led to antibiotic change in only 1.4% of the patients studied.
26. Potgieter PD, Hammond JM: Etiology of pneumonia requiring ICU admission. Chest 1992, 101:199-203.
27. Jimenez P, Saldias F, Meneses M, Silva ME, Wilson MG, Otth L: Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia. Chest 1993, 103:1023-1027.
28. Sorensen J, Forsberg P, Hakanson E, Maller R, Sederholm C, Soren L, Carlsson C: A new diagnostic approach to the patient with severe pneumonia. Scand J Infect Dis 1989, 21:33-41.
29. Hahn HH, Beaty HN: Transtracheal aspiration in the evaluation of patients with pneumonia. Ann Intern Med 1970, 72:183-187.
30. Osregaard L, Andersen PL: Etiology of community-acquired pneumonia: evaluation by transtracheal aspiration, blood cultures, or serology. Chest 1993, 104:1400-1407.
31. Schreiner A, Digranes A: Bacteriology of acute lower respiratory tract infections. J Infect 1979, 1(suppl 2):23-30.
32. Bella F, Tort J, Morera MA, Espaulella J, Armengol J: Value of bacterial antigen detection in the diagnostic yield of transthoracic needle aspiration in severe community-acquired pneumonia. Thorax 1993, 48:1227-1229.
33. Pachon J, Prados NM, Capote F, Cuello JA, Gamacho J, Verano A: Severe community-acquired pneumonia: etiology, prognosis, and treatment. Am Rev Respir Dis 1990, 142:369-373.
34. Pareja A, Bernal C, Leyva A, Piedrola G, Maroto C: Etiologic study of patients with community-acquired pneumonia. Chest 1992, 101:1207-1210.